Global Chloroquine Phosphate Tablets (COVID-19) Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Chloroquine Phosphate Tablets (COVID-19) Market Research Report 2024
Chloroquine phosphate is an antimalarial drug. It has been clinically proven to have a certain effect on the treatment of new crown pneumonia in the context of the outbreak of COVID-19.
According to Mr Accuracy reports’s new survey, global Chloroquine Phosphate Tablets (COVID-19) market is projected to reach US$ 51 million in 2034, increasing from US$ 34 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Chloroquine Phosphate Tablets (COVID-19) market research.
Key manufacturers engaged in the Chloroquine Phosphate Tablets (COVID-19) industry include Bayer, Rising Pharmaceutical, Sun Pharma, Shanghai Pharma, Sichuan Sunny Hope, Guangzhou Baiyunshan Guanghua Pharmaceutical, CSPC Group, KPC Group and Jinghua Pharmaceutical Group, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Chloroquine Phosphate Tablets (COVID-19) were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Chloroquine Phosphate Tablets (COVID-19) market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chloroquine Phosphate Tablets (COVID-19) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Bayer
Rising Pharmaceutical
Sun Pharma
Shanghai Pharma
Sichuan Sunny Hope
Guangzhou Baiyunshan Guanghua Pharmaceutical
CSPC Group
KPC Group
Jinghua Pharmaceutical Group
Zhongsheng Pharma
North China Pharmaceutical Group
Segment by Type
250mg
500mg
Arthritis
Malaria
COVID-19
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Chloroquine Phosphate Tablets (COVID-19) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Chloroquine Phosphate Tablets (COVID-19) market is projected to reach US$ 51 million in 2034, increasing from US$ 34 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Chloroquine Phosphate Tablets (COVID-19) market research.
Key manufacturers engaged in the Chloroquine Phosphate Tablets (COVID-19) industry include Bayer, Rising Pharmaceutical, Sun Pharma, Shanghai Pharma, Sichuan Sunny Hope, Guangzhou Baiyunshan Guanghua Pharmaceutical, CSPC Group, KPC Group and Jinghua Pharmaceutical Group, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Chloroquine Phosphate Tablets (COVID-19) were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Chloroquine Phosphate Tablets (COVID-19) market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chloroquine Phosphate Tablets (COVID-19) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bayer
Rising Pharmaceutical
Sun Pharma
Shanghai Pharma
Sichuan Sunny Hope
Guangzhou Baiyunshan Guanghua Pharmaceutical
CSPC Group
KPC Group
Jinghua Pharmaceutical Group
Zhongsheng Pharma
North China Pharmaceutical Group
Segment by Type
250mg
500mg
Segment by Application
Arthritis
Malaria
COVID-19
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Chloroquine Phosphate Tablets (COVID-19) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices